TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT01278953

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01278953
Other papers using this trial's data
  • Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study Circulation, 2015-09-08 DOI, PubMed 26260733

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01278953. Randomized; single masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2013-06 (actual). Results posted on 2016-02-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation
Acronym
TOCCASTAR
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Catheter ablation to treat paroxysmal atrial fibrillation
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01278953
Content hash
1f4829b85dd792b6773f73dd1f4db8c1307f7f63880015611c520745e0252e89